Uitgebreid zoeken
Instrumenten
| Naam | Mnemo | Beurs | Gemiddeld volume | Koers | Type | |
|---|---|---|---|---|---|---|
| LYNCH GROUP HOLDINGS LIMITED | LGL | Australian S.E. | 86 519 |
1,4
AUD
 | Aandeel | |
| MERRILL LYNCH DEPOSITOR INC. 6.0518% INDEX PLUS TRUST SERIES 2003-1 | IPB | Nyse | 1 077 |
25,35
USD
| Aandeel | |
| ETC - MERRILL LYNCH AFRICA LIONS INDEX | CPLCI | Swiss Exchange | 0 |
492,2
CHF
| Certificat | |
| ENDLOS INDEXZERTIFIKAT - LUS WIKIFOLIO-INDEX DOPPEL-MOMENTUM NACH LYNCH | Börse Stuttgart | - |
146,2
EUR
| Certificat | ||
| ENDLOS INDEXZERTIFIKAT - LUS WIKIFOLIO-INDEX CANSLIM MEETS LYNCH | Börse Stuttgart | - |
139,4
EUR
| Certificat | ||
| ENDLOS INDEXZERTIFIKAT - LUS WIKIFOLIO-INDEX DOPPEL-MOMENTUM NACH LYNCH | LS9QVU | Berne S.E. | - | - CHF
| Certificat | |
| MERRILL LYNCH S.A. IL TRIGGER RED NTS 27/03/37 | 87KO | London S.E. | - | - %
| Obligatie | |
| OPEN END PERLES - MERRILL LYNCH AFRICA LIONS INDEX | Swiss Exchange | - |
1.136
CHF
| Certificat | ||
| ENDLOS INDEXZERTIFIKAT - LUS WIKIFOLIO-INDEX BREITES VALUE-TRADING NACH LYNCH | Börse Stuttgart | - |
352
EUR
| Certificat | ||
| MERRILL LYNCH S.A. IDX LKD TRIGGER RED NTS 23/03/37 | 91IM | London S.E. | - | - %
| Obligatie |
Nieuws (17)
Bedrijven (3)
International Star, Inc. exploiteert via haar volledige dochteronderneming Budding Equity Inc. een op royalty's gebaseerd bedrijf dat intellectuele eigendomscontracten heeft met filmstudio's, die voorzien in het in licentie geven van dat intellectuele eig ...
Lynch Group Holdings Limited is een in Australië gevestigd bedrijf dat zich bezighoudt met de tuinbouwproductie en groothandel in bloemen en planten. Het bedrijf is een groothandelaar en kweker van bloemen en potplanten. Haar segmenten zijn Australië en C ...
Tapinator, Inc. ontwikkelt en publiceert spellen voor mobiele platforms. Het portfolio van het bedrijf omvat meer dan 300 titels met meer dan 500 miljoen mobiele downloads, waaronder spellen als Video Poker Classic en Crypto Trillionaire. Het bedrijf publ ...
Insiders
Mr. Kevin Lynch is Senior Credit Analyst at PNC Capital Advisors LLC.
Mr. Lynch was previously employed at Bank One Capital Corp.
and Standard & Poor's Financial Services LLC.
Mr. Lynch received his undergraduate degree in Public Policy from the Rochester Institute of Technology and graduate degree in Urban Planning and Environmental Studies from Rensselaer Polytechnic Institute.
Mr. Lynch is head of tax-exempt research at Banc One Capital Markets in Chicago where he provides analysis on electric utilities, project finance and special revenue issues.
Prior to joining the capital markets group, Mr. Lynch was a Director of Fixed Income Research for Bank One Investment Advisors providing credit support for the Bank’s $20 billion mutual fund portfolio.
Mr. Lynch began his career as an investment analyst first at Standard and Poor’s and then at Municipal Bond Investors Assurance in New York.
Mr. Lynch graduated from Rochester Institute of Technology with a BA in Public Policy and Finance and an MS from Rensselaer Polytechnic Institute in Urban Planning/Finance.
Kevin R.
Lynch founded SphynKx Therapeutics LLC in 2010, where he is working as Chief Scientific Officer from 2010.
Dr. Lynch also founded Catena Pharmaceuticals, Inc., where he worked as Vice President-Biological Sciences from 2010 to 2013.
Dr. Lynch also currently works at The University of Virginia School of Medicine, as Vice Chairman and the University of Virginia, as Professor-Pharmacology & Biochemistry from 2012.
Dr. Lynch received his doctorate degree in 1980 from the University of Rhode Island.
Geen resultaten voor deze zoekopdracht
- Beurs
- Uitgebreid zoeken
- Kevin Lynch
